COVID-19 Guidelines

CU Doctors are here for you!
Our clinics are open and able to serve you during this time for urgent in-person visits as well as virtual health services. Please call our clinics directly to schedule an appointment for both in person and virtual health.

Our number one priority is the health and safety of our patients, their family members, as well as our health care team. To honor this commitment we have implemented the following procedures:

  • Non-urgent medical appointments should be converted to telehealth visits or rescheduled if telehealth is not feasible.
  • Please bring your own face mask or covering to wear. Patients checking in must tell staff if they have: A fever, cold symptoms (cough, sore throat, runny nose, shortness of breath); Flu symptoms (fever, chills, body aches, etc.).
  • Adult patients may be allowed one asymptomatic person (at least 17 years old) for support; however, we reserve the right to deem a support person unnecessary at any time.
  • Pediatric patients may be allowed one asymptomatic adult (i.e. parent, guardian) for support.
  • For pediatric patients, please check the Children's Hospital Colorado website for updated COVID-19 related patient information.

Please call us about your current health care concerns. Please take care in following current public health guidelines. Please visit the Colorado COVID-19 website, for more information.

Thank you for doing your part to help keep everyone safe and healthy!

Stanley Szefler, MD
Professor, Pediatrics-Pulmonary Medicine

Director - Pediatric Asthma Research Program
Clinic (720) 777-6181
Print Profile
Email Profile

Gender: Male
Languages: English
Department, Section/Division: Pediatrics-Pulmonary Medicine

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
More providers at this location

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

  • Allergy and Immunology, Board Certification
  • Pediatrics, Board Certification
Conditions & Treatments
  • Immune System
  • Allergies
  • Lungs and Breathing
  • Asthma
Clinical Interest for Patients
I am interested in Childhood asthma; Asthma pharmacotherapy; Inhaled corticosteroids; Biomarkers; Predictors of treatment response and Monitoring treatment response; School-centered asthma programs.



Information for Referring Providers

Clinical Interests for Referring Providers
I am interested in Childhood asthma; Asthma pharmacotherapy; Inhaled corticosteroids; Biomarkers; Predictors of treatment response and Monitoring treatment response; School-Centered asthma programs.

Research Interest for Referring Providers
Dr. Szefler’s major contributions are directed toward the appropriate use of long-term control therapy in asthma, including the recognition of variability in response to asthma therapy. He has identified biomarkers and asthma characteristics that can be used to predict and thus individualize asthma therapy. Dr. Szefler is the Director of the Pediatric Asthma Research Program and Research Medical Director in the Breathing Institute of the Pediatric Pulmonary and Sleep Medicine Section at Children’s Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine. He is a former member of the Expert Panel for the National Heart, Lung, and Blood Institute’s National Asthma Education and Prevention Program on “Guidelines for the Diagnosis and Management of Asthma” and a former member of the Global Initiative for Asthma Science Committee. From 1997 through 1998, he was a Deputy Editor for the Journal of Allergy and Clinical Immunology. He has published more than 500 scientific articles and co-edited books on severe asthma, childhood asthma, pediatric allergy and immunology and personalized asthma management for clinicians. He is the Principal Investigator for the Denver site of the NHLBI AsthmaNet-Pediatrics Section and Co-Principal Investigator for the NHLBI PrecISE Network. For the past thirteen years, he has directed a school-based asthma program for the Denver Public School system funded by the Colorado Department of Public Health and Environment Colorado Cancer, Cardiovascular and Pulmonary Disease Program. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected, and to direct those children to state of the art asthma care. This program also developed a mentorship program for school nurses and was supported by Glaxo Smith Kline in order to set a national standard for school-based asthma management. A recent partnership with CareDOX is intended to provide an asthma module for school medical records.

Clinic Phone: (720) 777-6181
Fax Phone: (720) 777-7284

CV cv szefler update 112118.docx
Contact Us
In An Emergency: Please Dial 911

University of Colorado Medicine (CU Medicine)
Refer a Patient: 720-848-2828
Billing Questions: 303-493-7000

Twitter   Facebook
CU Doctors